COVID-19 RESPONSES FROM EUGEF RESEARCH GROUP

EuGEF Research Group is working closely with its collaborator XING Technologies in Queensland Australia to develop a the fast-and-easy detection of COVID-19 infection

 

A BREAKTHROUGH IN THE FAST-AND-EASY DETECTION OF COVID-19 INFECTION

A scientific consortium consisting of Bangladeshi research group Eukaryotic Gene Expression and Function (EuGEF) Research Group and Australian XING Technologies is going to unveil an accelerated research program to bring a rapid and easy diagnostic system for the COVID-19 infection to Bangladesh. EuGEF Research Group and XING Technologies have been working together to conduct medical science research to answer major questions of national health disparities under the direction of Bangladesh Medical Research Council (BMRC). Likewise, the aforesaid research program happens due to a timely initiative of the BMRC in the transition to the COVID-19 pandemic. This breakthrough detection method allows the diagnosis of infectious COVID-19 within minutes to detect the disease even at the very early phases of infection such as when there are no symptoms. The reagents used in this method are created using modern nanotechnology expertise, which facilitates the precise detection of COVID-19 causing novel coronavirus (SARS-CoV-2) by binding to its receptor-binding domain (RBD) of the Spike glycoprotein that projected outwards (see picture below). The reagents are designed based on the previous patent-relevant application WO 2014/093357 which has been granted by The Australian (AU2013359469) and European (EP2013863100) offices with national review by the US Office (US 2015-0377880) and is being conjointly developed under ISO 13485 and TGA/FDA/EMA roadmaps. The diagnostic process has been validated in laboratory tests with verification analysis on the inactivated virus from nasal wash material rather than from artificial sequences.  The application for a rapid clinical trial in Bangladesh has been sent to the National Research Ethics Committee (NREC) under the BMRC, which is currently awaiting final approval. With the approval of the NREC, BMRC will coordinate among various agencies and departments of the Bangladesh Government to announce the identification of the aforesaid detection system.

Picture2_edited.jpg
 

EuGEF Working Force

(to be updated)

Overall Supervision

M Mosaraf Hossain, PhD

Srikanta Chowdhury, PhD

Coordination with BMRC

M Wahiduzzaman, PhD

Tawhid Ahmed Shihan

Dhaka Group

Rashed Rezwan Parag

Alamgir Hossain

M Kaiser

M Mohaimenul Haque

Rubaiya Rafique

Sharif Nasibur Rahman

Mahfuza Khatun

Ayesha Siddiqua

Chittagong Group

Ramendu Parial

Rajib Kumar Shil

Dr. M Mizanur Rahman

Shafiqul Islam  

Hasan Murad 

Mohit Majumder

Umme Fahmida Easmin (Shompa)

Ridwan Ahmed 

M Jewel Mia

M Ejajur Rahman Himu

Rekha Akter

Bishu Sarkar

Shantu Dey

Umme Salma 

Maher Afrose 

Sumaiya Kawsar Sabiha

Rajshahi Group

Imtiaj Hasan, PhD

Sultana Rajia, PhD

M Pervez Hossain

M Missile Islam

Hossain M Hridoy

 

+880-1832-065684

©2021 by Eukaryotic Gene Expression and Function (EuGEF) Research Group